Zepbound Vial (Tirzepatide) – Prescription Weight Loss Injection | GIP/GLP-1 Therapy

Zepbound® (tirzepatide) vial is a prescription once-weekly injectable medication used for chronic weight management in adults with obesity or overweight with weight-related medical conditions. It is supplied in a multi-dose vial format for subcutaneous injection, used under medical supervision where vial-based administration is preferred.

Zepbound is a dual GIP and GLP-1 receptor agonist that targets key metabolic pathways to help reduce appetite, control food intake, and support clinically meaningful weight loss when combined with diet and exercise.

---

Key Features & Benefits

• Prescription weight loss injection (tirzepatide vial formulation)
• Dual GIP + GLP-1 receptor agonist therapy
• Supports clinically significant body weight reduction
• Helps reduce hunger, cravings, and calorie intake
• Once-weekly subcutaneous injection
• Used as part of a long-term weight management program

---

How Zepbound Works

Zepbound activates both GIP and GLP-1 receptors, which helps:

• Increase satiety and prolong fullness
• Reduce appetite and food consumption
• Slow gastric emptying
• Improve metabolic efficiency and fat utilization

This dual-action mechanism supports sustained weight loss over time when combined with lifestyle changes.

---

Important Information

Zepbound is a prescription-only medication intended for chronic weight management under healthcare supervision. It is not intended for short-term or cosmetic weight loss.

---

Common Side Effects

Common side effects may include nausea, vomiting, diarrhea, constipation, reduced appetite, and abdominal discomfort, particularly during dose initiation or escalation.